The person in charge
97 Centum jungang-ro, Haeundae-gu, Busan (48058)
WePlus was formed in May 2012, to introduce "Biometic" for the improvement of skin health. Our goal is to revitalize old skin to look young, as well as maintain a youthful skin appearance throughout a life time. We believe Biometric is the future and a new generation of the cosmetic field. If "Cosmetic" is the science of "beautify your skin", "Biometric" is the science to bring your skin health back to an optimal level. Our company is doing this by using natural and medical substances to manufacture products that will improve your skin health. Moreover, all of our products are put on the market only after being proven to be effective by clinical trials. No products are put on the market unless they show a positive effect and significant improvement to the health of your skin. During clinical trials, no participant experienced any adverse effects in using our products.
Furthermore, the key ingredients of our products are oligopeptides, polypeptides, and human stroma adipose stem cell conditioned media. Thus, our trade mark is "4GF", meaning the product contains 4 different kinds of Growth Factors which will revitalize your skin. The numbers following 4GF indicate the total amount of Growth Factors included in each product. For example, 4GF20 means 20ppm of four different kinds of Growth Factors are in the product. According to our clinical trials, our products show a significant reduction in the appearance of fine lines and wrinkles, an increase in skin firmness, whitening effects, and also show improvements in the appearance of both dry and oily skin.
Finally, our company continually puts the major part of our budget into research and development. Our goal is to produce the best and highest quality products to improve skin health. We do not just stop at improving skin health, we also put an emphasis on making human life better by providing education, health care, and food for poverty areas and underprivileged people in the world with a large proportion of company profit.